Carlo Santuccione

From Wikipedia, the free encyclopedia

Carlo Santuccione (born October 23, 1947 in Cepagatti) is an Italian sports doctor who is also known as Ali the Priceline Chemist. Santuccione worked with Francesco Conconi at the University of Ferrara in Italy at the Centro Studi Biomedici Applicati allo Sport or Biomedical Research Institute.

History

During the 1990s, Santuccione worked with Conconi the man that is said to have introduced Erythropoietin or EPO to the sport of cycling.[1]

Santuccione was suspended from acting as a physician from 1995-2000 by the Italian National Olympic Committee. Santuccione's name appeared in the case against Francesco Conconi; and he was subject to additional investigation in 2001. In 2004, the large scale operation Oil for Drugs began in 29 Italian provinces against a doping network that Santuccione was suspected to have headed. Doping products such as Testosterone anabolic steroids, EPO, Aranesp (Darbepoetin alfa) and blood transfusion equipment (Blood doping) were found and investigations were opened against 138 athletes (15 of whom were professional cyclists).[2] On December 18, 2007 Santuccione was given a lifetime ban by the Italian National Olympic Committee due to his involvement in the Oil for Drugs case and after having already serving a lengthy ban for a previous doping offense.[3][4] Riccardo Riccò who finished second in the 2008 Giro d'Italia and tested positive for a form of third generation EPO during the 2008 Tour de France named Santuccione as his supplier of the drug.[5]

List of racers

References

  1. "More Drug revelations". Cyclingnews.com. Retrieved 2008-04-25. 
  2. "The sport of the Doctors". Daily Peloton. Retrieved 2008-04-24. 
  3. "Santuccione banned for life". Cyclingnews.com. Retrieved 2008-05-03. 
  4. "Italian sports judge gives lifetime ban to doctor at center of doping probe". USA Today. 2007-12-17. Retrieved 2011-03-06. 
  5. "Riccò names supplier". Cyclingnews.com. Retrieved 2008-09-06. 


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.